UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparing Deflazacort and Prednisone in Duchenne Muscular Dystrophy

Journal of Neuromuscular Diseases, 2022-01, Vol.9 (4), p.463-476

2022

Volltextzugriff (PDF)

Glucocorticoid treatment for the prevention of scoliosis in children with Duchenne muscular dystrophy: long-term follow-up

Journal of bone and joint surgery. American volume, 2013-06, Vol.95 (12), p.1057-1061

2013

Volltextzugriff (PDF)

TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy

European journal of human genetics : EJHG, 2020-06, Vol.28 (6), p.815-825

2020

Volltextzugriff (PDF)

Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy

Nature communications, 2017-01, Vol.8 (1), p.14143-14143, Article 14143

2017

Volltextzugriff (PDF)

Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophy

Journal of bone and joint surgery. American volume, 2004-03, Vol.86 (3), p.519-524

2004

Volltextzugriff (PDF)

Development of a New Self-Reporting Instrument Measuring Benefits and Side Effects of Corticosteroids in Duchenne Muscular Dystrophy: Report from a Pilot Study

Journal of neuromuscular diseases, 2017, Vol.4 (3), p.217-236

2017

Volltextzugriff (PDF)

Duchenne muscular dystrophy

Pediatrics in review, 2006-03, Vol.27 (3), p.83-88

Biggar, W Douglas

2006

Volltextzugriff (PDF)

Duchenne Muscular Dystrophy: Current Knowledge, Treatment, and Future Prospects

Clinical orthopaedics and related research, 2002-08, Vol.401, p.88-106

2002

Volltextzugriff (PDF)

The Canadian experience with long-term deflazacort treatment in Duchenne muscular dystrophy

Acta myologica, 2012-05, Vol.31 (1), p.16-20

2012

Volltextzugriff (PDF)

The cooperative international neuromuscular research group Duchenne natural history study: Glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures

Muscle & nerve, 2013-07, Vol.48 (1), p.55-67

2013

Volltextzugriff (PDF)

The cooperative international neuromuscular research group duchenne natural history study-a longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used

Muscle & nerve, 2013-07, Vol.48 (1), p.32-54

2013

Volltextzugriff (PDF)

Age-related health risk behaviors of adolescents with physical disabilities

International journal of public health, 2004-01, Vol.49 (2), p.132-141

2004

Volltextzugriff (PDF)

Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy

Journal of pharmacokinetics and pharmacodynamics, 2019-10, Vol.46 (5), p.441-455

2019

Volltextzugriff (PDF)

Validation of the Actiheart activity monitor for measurement of activity energy expenditure in children and adolescents with chronic disease

European journal of clinical nutrition, 2010-12, Vol.64 (12), p.1494-1500

2010

Volltextzugriff (PDF)

Influence of hypothermia on the pharmacokinetics of gentamicin and theophylline in piglets

Critical care medicine, 1985-10, Vol.13 (10), p.844-847

1985

Volltextzugriff (PDF)

Influence of hypothermia, barbiturate therapy, and intracranial pressure monitoring on morbidity and mortality after near-drowning

Critical care medicine, 1986-06, Vol.14 (6), p.529-534

1986

Volltextzugriff (PDF)

Duchenne muscular dystrophy: current knowledge, treatment, and future prospects

Clinical orthopaedics and related research, 2002-08 (401), p.88-106

2002

Volltextzugriff (PDF)

Duchenne muscular dystrophy: Current knowledge, treatment, and future prospects : Genetics of childhood diseases

Clinical orthopaedics and related research, 2002 (401), p.88-106

2002

Volltextzugriff (PDF)

Enhancement of Human Neutrophil Bactericidal Activity by Chemotactic Factors

Infection and Immunity, 1979-05, Vol.24 (2), p.295-301

1979

Volltextzugriff (PDF)

Hydrogen Peroxide Release by Rat Alveolar Macrophages: Comparison with Blood Neutrophils

Infection and Immunity, 1978-02, Vol.19 (2), p.621-629

1978

Volltextzugriff (PDF)

885 KINETIC DIFFERENCES BETWEEN MATURE AND IMMATURE BLOOD NEUTROPHILS

Pediatric research, 1985-04, Vol.19 (4), p.258-258A

1985

Volltextzugriff (PDF)

Malakoplakia: evidence for an acquired disease secondary to immunosuppression

Transplantation, 1981-02, Vol.31 (2), p.109-112

1981

Volltextzugriff (PDF)

684 ABNORMAL CHEMOTAXIS AND BACTERIAL KILLING BY POLYMORPHONUCLEAR LEUKOCYTES IN A CHILD WITH RECURRENT INFECTION

Pediatric research, 1978-04, Vol.12, p.477-477

1978

Volltextzugriff (PDF)

Congenital asplenia: immunologic assessment and a clinical review of eight surviving patients

Pediatrics (Evanston), 1981-04, Vol.67 (4), p.548-551

1981

Volltextzugriff (PDF)

Clinical features and abnormal neutrophil function in disseminated staphylococcal disease

Pediatric infectious disease, 1985-03, Vol.4 (2), p.137-141

1985

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(59)
Reviews
(1)

Sprache

Englisch
(60)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparing Deflazacort and Prednisone in Duchenne Muscular Dystrophy

Glucocorticoid treatment for the prevention of scoliosis in children with Duchenne muscular dystrophy: long-term follow-up

TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy

Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy

Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophy

Development of a New Self-Reporting Instrument Measuring Benefits and Side Effects of Corticosteroids in Duchenne Muscular Dystrophy: Report from a Pilot Study

Duchenne muscular dystrophy

Duchenne Muscular Dystrophy: Current Knowledge, Treatment, and Future Prospects

The Canadian experience with long-term deflazacort treatment in Duchenne muscular dystrophy

The cooperative international neuromuscular research group duchenne natural history study-a longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used

Age-related health risk behaviors of adolescents with physical disabilities

Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy

Validation of the Actiheart activity monitor for measurement of activity energy expenditure in children and adolescents with chronic disease

Influence of hypothermia on the pharmacokinetics of gentamicin and theophylline in piglets

Influence of hypothermia, barbiturate therapy, and intracranial pressure monitoring on morbidity and mortality after near-drowning

Duchenne muscular dystrophy: current knowledge, treatment, and future prospects

Duchenne muscular dystrophy: Current knowledge, treatment, and future prospects : Genetics of childhood diseases

Enhancement of Human Neutrophil Bactericidal Activity by Chemotactic Factors

Hydrogen Peroxide Release by Rat Alveolar Macrophages: Comparison with Blood Neutrophils

885 KINETIC DIFFERENCES BETWEEN MATURE AND IMMATURE BLOOD NEUTROPHILS

Malakoplakia: evidence for an acquired disease secondary to immunosuppression

684 ABNORMAL CHEMOTAXIS AND BACTERIAL KILLING BY POLYMORPHONUCLEAR LEUKOCYTES IN A CHILD WITH RECURRENT INFECTION

Congenital asplenia: immunologic assessment and a clinical review of eight surviving patients

Clinical features and abnormal neutrophil function in disseminated staphylococcal disease

Aktive Filter

Suchergebnisse filtern